SAMLYN CAPITAL, LLC

Holdings History for Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)

Symbol: CRVS on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 6.67M shares
Security Ownership: 9.8%

Shares, Excluding Options vs Price

Value, Excluding Options

Samlyn Capital, LLC ownership in Corvus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (CRVS)

2025-02-14 - Samlyn Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.67M shares of Corvus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (CRVS). This represents 9.8% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Samlyn Capital, LLC	9.8%		$30.9M	6.67M			$4.63	13G/A	12/31/2024	14 Feb 2025 13:53:40

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0.57%	+0.18%	$35.7M	6.67M	+2,136,772	+47.2%	$5.35	Q4 2024
9/30/2024	0.39%	-0.14%	$23.9M	4.53M	-1,592,688	-26%	$5.28	Q3 2024
6/30/2024	0.19%	+0.12%	$11.1M	6.12M	+3,774,658	+161%	$1.82	Q2 2024
3/31/2024	0.07%	-0.01%	$4.18M	2.35M	-147,896	-5.92%	$1.78	Q1 2024
12/31/2023	0.1%	+0%	$4.39M	2.5M	+90,495	+3.76%	$1.76	Q4 2023
9/30/2023	0.06%	+0.01%	$3.51M	2.41M	+299,834	+14.2%	$1.46	Q3 2023
6/30/2023	0.08%	+0.08%	$4.82M	2.11M	+2,105,930	NEW	$2.29	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.